Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,200 | 41,261 | 26,362 | 64,767 | 40,833 |
| Marketable Securities | 76,834 | 77,475 | 86,166 | 62,169 | 66,135 |
| Receivables | 4,255 | 3,383 | 2,746 | 3,814 | 4,104 |
| Inventories | 9,440 | 8,301 | 10,050 | 9,819 | 10,283 |
| TOTAL | $119,898 | $132,062 | $126,459 | $141,763 | $122,114 |
| Non-Current Assets | |||||
| PPE Net | 7,861 | 8,492 | 9,236 | 10,544 | 11,655 |
| Other Non-Current Assets | 482 | 486 | 490 | 493 | 508 |
| TOTAL | $8,343 | $8,978 | $9,726 | $11,037 | $12,163 |
| Total Assets | $128,241 | $141,040 | $136,185 | $152,800 | $134,277 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,379 | 3,926 | 1,717 | 3,413 | 2,605 |
| Accrued Expenses | 9,225 | 7,678 | 7,905 | 8,506 | 8,950 |
| Other current liabilities | 1,304 | 220 | 2,102 | 201 | 191 |
| TOTAL | $27,967 | $22,513 | $22,555 | $22,479 | $15,093 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,714 | 13,525 | 13,347 | 13,173 | 13,007 |
| Deferred Revenues | 12,059 | 10,689 | 10,831 | 10,359 | 3,347 |
| Other Non-Current Liabilities | 3,546 | 3,736 | 4,066 | 4,730 | 5,045 |
| TOTAL | $41,259 | $43,002 | $44,450 | $46,778 | $18,786 |
| Total Liabilities | $69,226 | $65,515 | $67,005 | $69,257 | $33,879 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,630 | 70,495 | 70,459 | 66,152 | 65,250 |
| Common Shares | 71 | 70 | 66 | 681,614 | 677,995 |
| Retained earnings | -653,335 | -634,199 | -615,313 | -598,082 | -577,595 |
| Other shareholders' equity | 42 | 18 | 14 | 11 | -2 |
| TOTAL | $59,015 | $75,525 | $69,180 | $83,543 | $100,398 |
| Total Liabilities And Equity | $128,241 | $141,040 | $136,185 | $152,800 | $134,277 |